Impact of Green Tea on Cardiovascular Patients Suffering from Endothelial Dysfunction and Myocardial Infarction

Abstract

Globally tea consumption is common besides water. Green tea has been taken as a health stimulating drink since prehistoric time. From tea group polyphenols of green tea have been examined for cardiovascular disease (CVD) treatment. All around the world scientists have assessed the possible wellbeing profits of green tea for health due to its plentiful catechin, epigallocatechin-3-gallate (EGCG), in current centuries. Objective: To conclude the impact of green tea on cardiovascular patients suffering from endothelial dysfunction and myocardial infarction. Methods: Total of 21 cardiovascular patients, of both sexes, were randomly selected and followed up, with green tea intake, for two months. Two types of teas were used in the study, commonly available green tea in market and branded green tea. Their anthropometric measurements, body mass index, blood glucose level, blood lipid profile and electro cardio gram were done at the start, after a month and at the end of the trial. Results: The results showed that both local and branded green tea has an overall non-significant effect on body weight, blood glucose, LDL, HDL, triglyceride, cholesterol, and cholesterol: HDL and total lipids. As compared to control group both teas were effective in curing CVD. Comparative efficacy of both teas showed that Lipton green tea more significantly lowered the body weight, blood glucose, triglycerides, total lipids, cholesterol, SLDL, HDL and cholesterol: HDL was significantly increased. Conclusions: This study concluded that branded green tea is more effective in lowering weight, regulating the level of glucose in blood, modifying the lipid profile hence preventing the risk of CVD.